Structured products are back in the limelight as the world continues to grapple with the fallout stemming from the COVID-19 outbreak. Many are citing collateralized loan obligations, or CLOs, as posing an outsized risk in the current market environment. We disagree.
In this note, we define structured products, their inherent nuances as investment vehicles, and how, when accessed correctly, they present a source of opportunity.